University, Selah Technologies forge collaboration to advance cancer detection

Selah Technologies, an advanced materials manufacturer, and the University of South Carolina have signed a cooperative research agreement to investigate the use of Selah’s carbon quantum dots in biological diagnostic applications.

The collaboration will permit the university access to Selah’s proprietary Selah Dots™ while allowing Selah access to world-class research at the university NanoCenter. Cancer detection is just one of the applications that the university will be able to use with the technology.

”The university is excited by our collaboration with Selah,” said Dr. Harris Pastides, vice president for research and health sciences at the university. “Combining Selah’s unique nanomaterials with the outstanding researchers at the NanoCenter creates a win-win situation for us, Selah and, indeed, the State of South Carolina. Collaborations such as this one are a primary objective for the university and a driving force behind the development of Innovista.”

“Selah is thrilled to be advancing Clemson technologies via this collaboration with USC,” said Michael Bolick, President & CEO of Selah Technologies.

Selah Dots™ are carbon-based quantum dots that can be used for various applications, including life sciences, solar cells and anti-counterfeiting, among others. Selah Tubes™, enriched carbon nanotubes, have a number of applications due to their impressive electrical conductivity properties.

About the University of South Carolina NanoCenter
The NanoCenter is the university’s focal point for studies of nanometer-scale structures, their unique properties and their integration into functional units. It fosters multidisciplinary research and education efforts involving faculty whose combined expertise spans the disciplines of a comprehensive research university, including the arts and sciences, engineering and medicine, as well as other professional schools. For more information, visit www.nano.sc.edu.